DrugPatentWatch Database Preview
Drugs in Development Information for Melarsoprol
» See Plans and Pricing
What is the development status for investigational drug Melarsoprol?
Melarsoprol is an investigational drug.
There have been 3 clinical trials for Melarsoprol.
The most recent clinical trial was a Phase 3 trial, which was initiated on March 1st 2001.
The most common disease conditions in clinical trials are Trypanosomiasis, African, Trypanosomiasis, and [disabled in preview]. The leading clinical trial sponsors are Epicentre, Drugs for Neglected Diseases, and World Health Organization.
Summary for Melarsoprol
| US Patents | 0 |
| International Patents | 0 |
| US Patent Applications | 1,414 |
| WIPO Patent Applications | 1,119 |
| Japanese Patent Applications | 464 |
| Clinical Trial Progress | Phase 3 (2001-03-01) |
| Vendors | 0 |
Recent Clinical Trials for Melarsoprol
| Title | Sponsor | Phase |
|---|---|---|
| Efficacy and Safety of Fexinidazole in Patients With Human African Trypanosomiasis (HAT) Due to Trypanosoma Brucei Rhodesiense | European and Developing Countries Clinical Trials Partnership (EDCTP) | Phase 2/Phase 3 |
| Efficacy and Safety of Fexinidazole in Patients With Human African Trypanosomiasis (HAT) Due to Trypanosoma Brucei Rhodesiense | Drugs for Neglected Diseases | Phase 2/Phase 3 |
| Randomized Clinical Trial of Three Drug Combinations for Late-Stage Gambiense Human African Trypanosomiasis | Embassy of France in Uganda | Phase 3 |
Clinical Trial Summary for Melarsoprol
Top disease conditions for Melarsoprol
Top clinical trial sponsors for Melarsoprol
US Patents for Melarsoprol
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
